Uh-oh! This study is no longer available.
Migraine – Ages 6 – 17
PMG Research of Bristol
6 - 17
A research study is evaluating an investigational medication, already FDA-approved for adults, that may reduce migraine attacks in children and teens.
This research study may be an option if your child:
- Is between the ages of 6 – 17
- Has a migraine diagnosis
- Has experienced at least 1 migraine in the last 6 months
- Weighs at least 37.5 pounds
Other criteria apply.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration
Financial compensation may be provided for time and travel expenses.